The tau pathology characteristic of AD is comprised of a mixture of all 3R and 4R tau species (3R/4R), as these are the tau aggregates that define chronic traumatic encephalopathy (CTE), and the majority of PET tracers developed thus far target the aggregates of 3R/4R tau [22]. The gene discussed is MAPT; the disease is Alzheimer disease.